{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:39:48Z","timestamp":1784302788800,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"DOI":"10.1007\/s00784-023-04981-9","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T07:02:27Z","timestamp":1681110147000},"page":"2449-2463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson\u2019s disease: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"27","author":[{"given":"Luiz Carlos","family":"Santos Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ronaldo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Lu\u00eds","family":"Faria-e-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyana Caldeira","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"4981_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.01.018","journal-title":"Free Radic Biol Med"},{"key":"4981_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 46:292\u2013300. https:\/\/doi.org\/10.1159\/000445751","journal-title":"Neuroepidemiology"},{"key":"4981_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s disease and Parkinsonism. Am J Med 132:802\u2013807. https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001","journal-title":"Am J Med"},{"issue":"6","key":"4981_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"4981_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00455-020-10102-5","volume":"35","author":"DJ Van Wamelen","year":"2020","unstructured":"Van Wamelen DJ, Leta V, Johnson J, Ocampo CL, Podlewska AM, Rukavina K, Rizos A, Martinez-martin P, Chaudhuri KR (2020) Drooling in Parkinson\u2019s disease: prevalence and progression from the non-motor international longitudinal study. Dysphagia 35:955\u2013961. https:\/\/doi.org\/10.1007\/s00455-020-10102-5","journal-title":"Dysphagia"},{"issue":"10","key":"4981_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/14737175.2021.1979959","volume":"21","author":"WH Jost","year":"2021","unstructured":"Jost WH, Steffen A, Steffen B (2021) A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients. Expert Rev Neurother 21(10):1059\u20131068. https:\/\/doi.org\/10.1080\/14737175.2021.1979959","journal-title":"Expert Rev Neurother"},{"key":"4981_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","volume":"20","author":"P Srivanitchapoom","year":"2014","unstructured":"Srivanitchapoom P, Pandey S, Hallett M (2014) Drooling in Parkinson\u2019s disease: a review. Parkinsonism Relat Disord 20:1109\u20131118. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.08.013","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"4981_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/toxins12110691","volume":"12","author":"J Isaacson","year":"2020","unstructured":"Isaacson J, Patel S, Torres-Yaghi Y, Pag\u00e1n F (2020) Sialorrhea in Parkinson\u2019s disease. Toxins (Basel) 12(11):691. https:\/\/doi.org\/10.3390\/toxins12110691","journal-title":"Toxins (Basel)"},{"key":"4981_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/practneurol-2016-001515","volume":"17","author":"AJ Mcgeachan","year":"2017","unstructured":"Mcgeachan AJ, Mcdermott CJ (2017) Management of oral secretions in neurological disease. Pract Neurol 17:96\u2013103. https:\/\/doi.org\/10.1136\/practneurol-2016-001515","journal-title":"Pract Neurol"},{"key":"4981_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00784-016-1826-z","volume":"21","author":"J Tiigim\u00e4e-Saar","year":"2017","unstructured":"Tiigim\u00e4e-Saar J, Taba P, Tamme T (2017) Does Botulinum neurotoxin type A treatment for sialorrhea change oral health? Clin Oral Investig 21:795\u2013800. https:\/\/doi.org\/10.1007\/s00784-016-1826-z","journal-title":"Clin Oral Investig"},{"key":"4981_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jocn.2018.02.011","volume":"51","author":"K Sridharan","year":"2018","unstructured":"Sridharan K, Sivaramakrishnan G (2018) Pharmacological interventions for treating sialorrhea associated with neurological disorders: a mixed treatment network meta-analysis of randomized controlled trials. J Clin Neurosci 51:12\u201317. https:\/\/doi.org\/10.1016\/j.jocn.2018.02.011","journal-title":"J Clin Neurosci"},{"key":"4981_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/toxins12110691","volume":"12","author":"J Isaacson","year":"2020","unstructured":"Isaacson J, Patel S, Torres-yaghi Y, Pag\u00e1n F (2020) Sialorrhea in Parkinson\u2019s disease. Toxins (Basel) 12:691. https:\/\/doi.org\/10.3390\/toxins12110691","journal-title":"Toxins (Basel)"},{"key":"4981_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catal\u00e1-L\u00f3pez F, G\u00f8tzsche PC, Dickersin K, Boutron I, Altman DG, Moher D (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162:777\u2013784. https:\/\/doi.org\/10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"4981_CR14","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2011) Cochrane Handbook for systematic reviews of Interventions 5.1.0. Available at: https:\/\/handbook-5-1.cochrane.org\/. Accessed 8 Nov 2021"},{"key":"4981_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00213-009-1689-y","volume":"207","author":"S Steinlechner","year":"2010","unstructured":"Steinlechner S, Klein C, Moser A, Lencer R, Hagenah J (2010) Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea. Psychopharmacology 207:593\u2013597. https:\/\/doi.org\/10.1007\/s00213-009-1689-y","journal-title":"Psychopharmacology"},{"key":"4981_CR16","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing the risk of bias in randomized trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"4981_CR17","doi-asserted-by":"publisher","DOI":"10.1201\/9781003107347","volume-title":"Doing meta-analysis with R: a hands-on guide","author":"M Harrer","year":"2021","unstructured":"Harrer M, Cuijpers P, Furukawa TA, Ebert DD (2021) Doing meta-analysis with R: a hands-on guide. CRC Press, Boca Raton"},{"issue":"15","key":"4981_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"31","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G (2015) Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol 31(15):58. https:\/\/doi.org\/10.1186\/s12874-015-0060-8","journal-title":"BMC Med Res Methodol"},{"key":"4981_CR19","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","volume":"9","author":"G Salanti","year":"2014","unstructured":"Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP (2014) Evaluating the quality of evidence from a network meta-analysis. PLoS One 9:e99682. https:\/\/doi.org\/10.1371\/journal.pone.0099682","journal-title":"PLoS One"},{"key":"4981_CR20","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, Salanti G (2020) CINeMA: an approach for assessing confidence in the results of a network meta-analysis. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med 17:e1003082. https:\/\/doi.org\/10.1371\/journal.pmed.1003082","journal-title":"PLoS Med"},{"key":"4981_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1212\/wnl.61.9.1279","volume":"61","author":"A Lipp","year":"2003","unstructured":"Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G (2003) A randomized trial of botulinum toxin A for treatment of drooling. Neurology 61:1279\u20131281. https:\/\/doi.org\/10.1212\/wnl.61.9.1279","journal-title":"Neurology"},{"key":"4981_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/mds.10420","volume":"18","author":"F Mancini","year":"2003","unstructured":"Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C (2003) Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 18:685\u2013688. https:\/\/doi.org\/10.1002\/mds.10420","journal-title":"Mov Disord"},{"key":"4981_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1212\/01.wnl.0000101713.81253.4c","volume":"62","author":"WG Ondo","year":"2004","unstructured":"Ondo WG, Hunter C, Moore W (2004) A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson\u2019s disease. Neurology 62:37\u201340. https:\/\/doi.org\/10.1212\/01.wnl.0000101713.81253.4c","journal-title":"Neurology"},{"key":"4981_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/mds.20793","volume":"21","author":"G Lagalla","year":"2006","unstructured":"Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2006) Botulinum toxin type A for drooling in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study. Mov Disord 21:704\u2013707. https:\/\/doi.org\/10.1002\/mds.20793","journal-title":"Mov Disord"},{"key":"4981_CR25","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/mds.21730","volume":"22","author":"TR Thomsen","year":"2007","unstructured":"Thomsen TR, Galpern WR, Asante A, Arenovich T, Fox SH (2007) Ipratropium bromide spray as a treatment for sialorrhea in Parkinson\u2019s disease. Mov Disord 22:2268\u20132273. https:\/\/doi.org\/10.1002\/mds.21730","journal-title":"Mov Disord"},{"key":"4981_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","volume":"256","author":"G Lagalla","year":"2009","unstructured":"Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2009) Long-lasting benefits of botulinum toxin type B in Parkinson\u2019s disease-related drooling. J Neurol 256:563\u2013567. https:\/\/doi.org\/10.1007\/s00415-009-0085-1","journal-title":"J Neurol"},{"key":"4981_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181d8c1b7","volume":"74","author":"ME Arbouw","year":"2010","unstructured":"Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Neef C, van Vugt JP (2010) Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology 74:1203\u20131207. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d8c1b7","journal-title":"Neurology"},{"key":"4981_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.23473","volume":"26","author":"A Guidubaldi","year":"2011","unstructured":"Guidubaldi A, Fasano A, Ialongo T, Piano C, Pompili M, Mascian\u00e0 R, Siciliani L, Sabatelli M, Bentivoglio AR (2011) Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson\u2019s disease. Mov Disord 26:313\u2013319. https:\/\/doi.org\/10.1002\/mds.23473","journal-title":"Mov Disord"},{"key":"4981_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/mds.23929","volume":"27","author":"R Chinnapongse","year":"2012","unstructured":"Chinnapongse R, Gullo K, Nemeth P, Zhang Y, Griggs L (2012) Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson\u2019s disease: a prospective, double-blind trial. Mov Disord 27:219\u2013226. https:\/\/doi.org\/10.1002\/mds.23929","journal-title":"Mov Disord"},{"key":"4981_CR30","doi-asserted-by":"publisher","first-page":"e1982","DOI":"10.1212\/WNL.0000000000007368","volume":"92","author":"WH Jost","year":"2019","unstructured":"Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqu\u00e9 B, Csik\u00f3s J, Cairney CJ, Blitzer A (2019) SIAXI: placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea. Neurology 92:e1982\u2013e1991. https:\/\/doi.org\/10.1212\/WNL.0000000000007368","journal-title":"Neurology"},{"key":"4981_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/jamaneurol.2019.4565","volume":"77","author":"SH Isaacson","year":"2020","unstructured":"Isaacson SH, Ondo W, Jackson CE, Trosch RM, Molho E, Pagan F, Lew M, Dashtipour K, Clinch T, Espay AJ, MYSTICOL Study Group (2020) Safety and efficacy of rimabotulinumtoxinB for treatment of sialorrhea in adults: a randomized clinical trial. JAMA Neurol 77:461\u2013469. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4565","journal-title":"JAMA Neurol"},{"key":"4981_CR32","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/mds.28196","volume":"35","author":"TA Mestre","year":"2020","unstructured":"Mestre TA, Freitas E, Basndwah A, Lopez MR, de Oliveira LM, Al-Shorafat DM, Zhang T, Lui JP, Grimes D, Fox SH (2020) Glycopyrrolate improves disability from sialorrhea in Parkinson\u2019s disease: a 12-week controlled trial. Mov Disord 35:2319\u20132323. https:\/\/doi.org\/10.1002\/mds.28196","journal-title":"Mov Disord"},{"key":"4981_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2288-13-35","volume":"13","author":"U Krahn","year":"2013","unstructured":"Krahn U, Binder H, K\u00f6nig J (2013) A graphical tool for locating inconsistency in network meta-analyses. BMC Med Res Methodol 13:35. https:\/\/doi.org\/10.1186\/1471-2288-13-35","journal-title":"BMC Med Res Methodol"},{"key":"4981_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64:163\u2013171. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.03.016","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"4981_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13643-017-0473-z","volume":"6","author":"L Mbuagbaw","year":"2017","unstructured":"Mbuagbaw L, Rochwerg B, Jaeschke R, Heels-Andsell D, Alhazzani W, Thabane L, Guyatt GH (2017) Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev 6(1):79. https:\/\/doi.org\/10.1186\/s13643-017-0473-z","journal-title":"Syst Rev"},{"key":"4981_CR36","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. Routledge, Oxfordshire"},{"key":"4981_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/jcm8030317","volume":"8","author":"JA Ruiz-Roca","year":"2019","unstructured":"Ruiz-Roca JA, Pons-Fuster E, Lopez-Jornet P (2019) Effectiveness of the botulinum toxin for treating sialorrhea in patients with parkinson\u2019s disease: a systematic review. J Clin Med 8:317. https:\/\/doi.org\/10.3390\/jcm8030317","journal-title":"J Clin Med"},{"key":"4981_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1590\/S1679-45082016RB3594","volume":"14","author":"AF Filho Oliveira","year":"2016","unstructured":"Filho Oliveira AF, Silva GA, Almeida DM (2016) Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review. Einstein (Sao Paulo) 14:431\u2013434. https:\/\/doi.org\/10.1590\/S1679-45082016RB3594","journal-title":"Einstein (Sao Paulo)"},{"key":"4981_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40734-017-0055-1","volume":"4","author":"K Dashtipour","year":"2017","unstructured":"Dashtipour K, Bhidayasiri R, Chen JJ, Jabbari B, Lew M, Torres-Russotto D (2017) RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials. J Clin Mov Disord 4:9. https:\/\/doi.org\/10.1186\/s40734-017-0055-1","journal-title":"J Clin Mov Disord"},{"key":"4981_CR40","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/children8121089","volume":"8","author":"SA Hung","year":"2021","unstructured":"Hung SA, Liao CL, Lin WP, Hsu JC, Guo YH, Lin YC (2021) Botulinum toxin injections for treatment of drooling in children with cerebral palsy: a systematic review and meta-analysis. Children (Basel) 8:1089. https:\/\/doi.org\/10.3390\/children8121089","journal-title":"Children (Basel)"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-04981-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-023-04981-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-04981-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T12:30:56Z","timestamp":1686659456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-023-04981-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["4981"],"URL":"https:\/\/doi.org\/10.1007\/s00784-023-04981-9","relation":{},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}